![Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog](https://knowmedge.com/blog/wp-content/uploads/2016/12/Blog-Acute-Coronary-Syndrome.png)
Topic Refresher: Acute Coronary Syndrome Medications : USMLE / Internal Medicine ABIM Board Exam Review Blog
![Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology](https://www.ajconline.org/cms/asset/1d9275c4-504d-4d8d-9b82-498a1a14e319/gr1.jpg)
Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - American Journal of Cardiology
![Flow chart of the study. ACS indicates acute coronary syndrome; HF,... | Download Scientific Diagram Flow chart of the study. ACS indicates acute coronary syndrome; HF,... | Download Scientific Diagram](https://www.researchgate.net/publication/321971782/figure/fig1/AS:574275830259712@1513929435871/Flow-chart-of-the-study-ACS-indicates-acute-coronary-syndrome-HF-heart-failure-LV.png)
Flow chart of the study. ACS indicates acute coronary syndrome; HF,... | Download Scientific Diagram
![Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S1885585714004034:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w99KBUZDJuFlLjKo5clFAJaBzV3lXurjotj++nFCAYF1Nd9PGxDtl86eeObYuxNzwWnkuzoSLVJ8q4bnH18KplZIYR9C+DwI/77WKX2Icnksqq2CYk5bOhKzY5iDqKOT4+Fm8Bk9JHHuW3aQfLvUksrnBxqbYqhgKg6gAVI+aH8PCtxBCsWCvotQiifKW0RPhWYSvacMNsw+rxGF3H8OuGOxMMINu31TgwMeQM4zgvkRhjs1HYsB3FJQ77KqrzjLvPKN7HEV4qKPaGKx/L0+67/0=)
Prognostic Benefit of Beta-blockers After Acute Coronary Syndrome With Preserved Systolic Function. Still Relevant Today? | Revista Española de Cardiología
![BETA BLOCKER POST ACS IN PATIENTS WITH PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION | Journal of the American College of Cardiology BETA BLOCKER POST ACS IN PATIENTS WITH PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/669892fb-6d71-4dfb-9574-ed7ab9ad9810/s0735-1097(17)33432-0.fp.png)
BETA BLOCKER POST ACS IN PATIENTS WITH PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION | Journal of the American College of Cardiology
![Beta-blockers in acute coronary syndrome patients: The concept of 'gradient of benefit' | Revista Portuguesa de Cardiologia Beta-blockers in acute coronary syndrome patients: The concept of 'gradient of benefit' | Revista Portuguesa de Cardiologia](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0870255121003486:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w94UphxYc+GPca8Z7OggvdfJQF4SIqTc4zp8SrbcUWBiKmVgt7PBOV8b/TxsdqahTQ1OaN3/+9C/+sDX45Aq5HhGh9IoZkG3R4R+fWDTRWrwPUnhPlHh3EhWxuvqtORUTGyNbHPAkau7+1ANQ6y336xQ8dyy9MzEIqGHrmD9S7v7P9m+qWVfZqGoEDimKftTETt8eKP9euu6ckz7+vLiizv1NKjhioDuybpkuY6BUCnnxbCCrk5aIYyl/TaAVw7yx3/0j0CUOTz7d+F9N6aEQc6k=)
Beta-blockers in acute coronary syndrome patients: The concept of 'gradient of benefit' | Revista Portuguesa de Cardiologia
![β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute](https://www.ahajournals.org/cms/asset/717fdd76-a65b-4030-bc3c-68025a77cc12/jah32828-fig-0001.gif)
β‐Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In‐Hospital and 12‐Month Outcome: Results From the GULF‐RACE 2 (Gulf Registry of Acute
![PDF) What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis PDF) What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis](https://i1.rgstatic.net/publication/329664476_What_is_the_role_of_beta-blockers_in_a_contemporary_treatment_cohort_of_patients_with_acute_coronary_syndrome_A_propensity-score_matching_analysis/links/5e62c709a6fdcc37dd0b3846/largepreview.png)
PDF) What is the role of beta-blockers in a contemporary treatment cohort of patients with acute coronary syndrome? A propensity-score matching analysis
Systematic review of β blocker, aspirin, and statin in critically ill patients: importance of severity of illness and cardiac t
![The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | Journal of the American College of Cardiology The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/3ed82da2-4538-4a24-8989-d870e4dc6730/fx1.jpg)
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) | Journal of the American College of Cardiology
![Systematic review of β blocker, aspirin, and statin in critically ill patients: importance of severity of illness and cardiac troponin | Journal of Investigative Medicine Systematic review of β blocker, aspirin, and statin in critically ill patients: importance of severity of illness and cardiac troponin | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/65/4/747/F1.large.jpg)